Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, ...

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemiaFinal European Commission decision ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

The FDA has expanded the approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and can delay chemotherapy.

Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ...

Use of positive airway pressure therapy decreased the risk for all-cause and cardiovascular mortality in adults with ...

PROCEPT BioRobotics announced positive WATER III trial results for Aquablation therapy in large prostates, showing effective outcomes and reduced complications. PROCEPT BioRobotics Corporation ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

Behavioral therapy can help people with ADHD develop new, more positive behaviors and help them manage their symptoms more effectively. Behavioral therapy may work alongside medication and is ...

The Food and Drug Administration (FDA) has expanded the approval of Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) to include patients with ...